Barclays Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN - Get Free Report) had its price target dropped by investment analysts at Barclays from $83.00 to $79.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. Barclays's price target would indicate a potential upside of 22.22% from the stock's previous close.

A number of other brokerages have also recently issued reports on RYAN. The Goldman Sachs Group raised shares of Ryan Specialty from a "neutral" rating to a "buy" rating and increased their target price for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. TD Cowen started coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 target price for the company. Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Wells Fargo & Company dropped their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Finally, Morgan Stanley increased their target price on shares of Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty has a consensus rating of "Moderate Buy" and an average target price of $75.00.

Ryan Specialty Stock Performance

NYSE RYAN traded down $1.58 during trading hours on Monday, hitting $64.64. 831,672 shares of the stock were exchanged, compared to its average volume of 923,794. The company has a market cap of $16.96 billion, a price-to-earnings ratio of 190.12, a price-to-earnings-growth ratio of 1.76 and a beta of 0.66. Ryan Specialty has a 12-month low of $55.67 and a 12-month high of $77.16. The stock has a 50-day moving average of $68.14 and a 200 day moving average of $68.11. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 3.45.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.39. The firm had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. The firm's revenue for the quarter was up 25.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.35 earnings per share. As a group, equities research analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current year.

Insider Activity at Ryan Specialty

In related news, Director David P. Bolger sold 5,000 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total transaction of $354,000.00. Following the sale, the director owned 71,467 shares in the company, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Mark Stephen Katz sold 14,377 shares of the firm's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the sale, the executive vice president owned 1,117 shares in the company, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is owned by corporate insiders.

Institutional Trading of Ryan Specialty

A number of hedge funds have recently bought and sold shares of the company. Financiere des Professionnels Fonds d investissement inc. acquired a new stake in Ryan Specialty during the second quarter worth approximately $257,000. Central Pacific Bank Trust Division acquired a new stake in Ryan Specialty during the second quarter worth approximately $31,000. Voya Investment Management LLC boosted its position in Ryan Specialty by 43.5% during the first quarter. Voya Investment Management LLC now owns 147,872 shares of the company's stock worth $10,923,000 after acquiring an additional 44,843 shares during the last quarter. Flaharty Asset Management LLC boosted its position in Ryan Specialty by 40.0% during the first quarter. Flaharty Asset Management LLC now owns 7,000 shares of the company's stock worth $517,000 after acquiring an additional 2,000 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Ryan Specialty by 11.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company's stock worth $24,586,000 after acquiring an additional 33,667 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.